Literature DB >> 16437362

Prevalence and classification of headache in patients with systemic lupus erythematosus.

Bruno Lessa1, Alex Santana, Isabella Lima, José Martônio Almeida, Mittermayer Santiago.   

Abstract

Studies on the prevalence of headache in systemic lupus erythematosus (SLE) have shown that it varies from 32 to 78%. The purpose of our study was to determine the prevalence and characteristics of headache in SLE compared with patients with different types of diffuse connective tissue diseases (DCTD) and its relationship with clinical and laboratory manifestations of SLE. We studied patients with SLE (SLE group) and patients with DCTD (control group). All patients were made to answer questionnaire to assess the presence of headache, characterized by at least five episodes of headache during the last year, which was classified according to the International Headache Society criteria. A total of 207 patients were studied, 115 in SLE group and 92 in the control group. The 1-year prevalence of headache was 75.7% in SLE group and 66% in the control group. When the groups were analyzed, 66.1% met the diagnostic criteria for migraine in the SLE group compared with 52.2% in the control group (p=0.04) and 13.9% for tension-type headache in SLE group compared with 16.3% in the control group. The former was the only variable that reached statistical significance comparing the two groups. Both headache and migraine were associated with Raynaud's phenomenon in SLE patients (odds ratio of 2.80, 95% confidence interval: 1.11-7.05, p=0.02 and odds ratio of 2.34, 95% confidence interval: 1.04-5.23, p=0.03, respectively). These results suggest that headache is a common manifestation in SLE and in other DCTD and we cannot exclude the possibility that it may be related to the emotional stress induced by such clinical situations.

Entities:  

Mesh:

Year:  2006        PMID: 16437362     DOI: 10.1007/s10067-005-0186-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  35 in total

1.  Frequency of headache in the medical students of Santa Catarina's Federal University.

Authors:  M Z da Costa; C B Soares; L M Heinisch; R H Heinisch
Journal:  Headache       Date:  2000-10       Impact factor: 5.887

2.  Lupus anticoagulant, antiphospholipid antibodies and migraine.

Authors:  M J Hogan; D G Brunet; P M Ford; D Lillicrap
Journal:  Can J Neurol Sci       Date:  1988-11       Impact factor: 2.104

3.  Lack of association between antiphospholipid antibodies and migraine in children.

Authors:  A Verrotti; F Cieri; P Pelliccia; G Morgese; F Chiarelli
Journal:  Int J Clin Lab Res       Date:  2000

4.  Prevalence and clinical characteristics of headache in a rural community in Oman.

Authors:  Dirk Deleu; Mushtaq A Khan; Tariq A H Al Shehab
Journal:  Headache       Date:  2002 Nov-Dec       Impact factor: 5.887

Review 5.  The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation.

Authors:  F G I Jennekens; L Kater
Journal:  Rheumatology (Oxford)       Date:  2002-06       Impact factor: 7.580

6.  Neuropsychiatric syndromes in lupus: prevalence using standardized definitions.

Authors:  R L Brey; S L Holliday; A R Saklad; M G Navarrete; D Hermosillo-Romo; C L Stallworth; C R Valdez; A Escalante; I del Rincón; G Gronseth; C B Rhine; P Padilla; D McGlasson
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

7.  Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus.

Authors:  J Montalbán; R Cervera; J Font; J Ordi; J Vianna; H J Haga; M Tintoré; M A Khamashta; G R Hughes
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

8.  Migrainous phenomena in systemic lupus erythematosus.

Authors:  K D Brandt; S Lessell
Journal:  Arthritis Rheum       Date:  1978 Jan-Feb

9.  A prospective study of chronic or recurrent headache in systemic lupus erythematosus.

Authors:  J Vázquez-Cruz; H Traboulssi; A Rodriquez-De la Serna; C Geli; C Roig; C Diaz
Journal:  Headache       Date:  1990-03       Impact factor: 5.887

10.  Structural and neurochemical markers of brain injury in the migraine diathesis of systemic lupus erythematosus.

Authors:  C L Rozell; W L Sibbitt; W M Brooks
Journal:  Cephalalgia       Date:  1998-05       Impact factor: 6.292

View more
  9 in total

1.  Migraine: risk factor and comorbidity.

Authors:  G Giannini; S Cevoli; L Sambati; P Cortelli
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

Review 2.  Comorbidity of Migraine.

Authors:  Şebnem Biçakci
Journal:  Noro Psikiyatr Ars       Date:  2013-08-01       Impact factor: 1.339

3.  Neuropsychiatric manifestations of systemic lupus erythematosus: Iranian experience.

Authors:  Afshin Borhani Haghighi; Shahab Ghasem Haza
Journal:  Ann Indian Acad Neurol       Date:  2010-04       Impact factor: 1.383

4.  Case reports on two patients with episodic vertigo, fluctuating hearing loss and migraine responding to prophylactic drugs for migraine. Menière's disease or migraine-associated vertigo?

Authors:  R Teggi; B Fabiano; P Recanati; P Limardo; M Bussi
Journal:  Acta Otorhinolaryngol Ital       Date:  2010-08       Impact factor: 2.124

5.  The Prevalence of Headache in Crohn's Disease: Single-Center Experience.

Authors:  Ulker Anadol Kelleci; Turan Calhan; Abdurrahman Sahin; Resul Kahraman; Kamil Ozdil; Haci Mehmet Sokmen; Destina Yalcin
Journal:  Gastroenterol Res Pract       Date:  2016-01-19       Impact factor: 2.260

6.  Assessment of Headache in Asthma Patients.

Authors:  Adil Can Gungen; Belma Gungen
Journal:  Pak J Med Sci       Date:  2017 Jan-Feb       Impact factor: 1.088

7.  H-magnetic resonance spectroscopy: diagnostic tool in recurrent headache in systemic lupus erythematosus. A case report.

Authors:  Emanuele Tinelli; Simona Pontecorvo; Manuela Morreale; Francesca Caramia; Ada Francia
Journal:  Radiol Case Rep       Date:  2018-11-06

Review 8.  Headache and immunological/autoimmune disorders: a comprehensive review of available epidemiological evidence with insights on potential underlying mechanisms.

Authors:  Leonardo Biscetti; Gioacchino De Vanna; Elena Cresta; Ilenia Corbelli; Lorenzo Gaetani; Letizia Cupini; Paolo Calabresi; Paola Sarchielli
Journal:  J Neuroinflammation       Date:  2021-11-08       Impact factor: 8.322

Review 9.  Immunologic aspects of migraine: A review of literature.

Authors:  Mehrnaz Salahi; Sina Parsa; Delaram Nourmohammadi; Zahra Razmkhah; Omid Salimi; Mohammadreza Rahmani; Saeid Zivary; Monireh Askarzadeh; Mohammad Amin Tapak; Ali Vaezi; Hamidreza Sadeghsalehi; Shirin Yaghoobpoor; Mehran Mottahedi; Setareh Garousi; Niloofar Deravi
Journal:  Front Neurol       Date:  2022-09-28       Impact factor: 4.086

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.